Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Alterity Therapeutics Ltd. ( (AU:ATH) ).
Alterity Therapeutics Limited has announced an Extraordinary General Meeting to be held on March 31, 2025, where shareholders will consider resolutions to ratify the prior issue of shares and approve the issuance of additional shares. This meeting is significant as it addresses the company’s capital structure, potentially impacting its financial strategy and market positioning by involving sophisticated investors in its funding activities.
More about Alterity Therapeutics Ltd.
Alterity Therapeutics Limited operates in the biotechnology industry, focusing on developing therapeutic products for neurodegenerative diseases. The company is engaged in creating innovative treatments aimed at addressing unmet medical needs in this specialized market.
Average Trading Volume: 100
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $46.18M
See more insights into ATH stock on TipRanks’ Stock Analysis page.